The structure of Pneumocystis carinii dihydrofolate reductase to 1.9 A resolution.
BACKGROUND: The fungal pathogen Pneumocystis carinii causes a pneumonia which is an opportunistic infection of AIDS patients. Current therapy includes the dihydrofolate reductase (DHFR) inhibitor trimethoprim which is selective but only a relatively weak inhibitor of the enzyme for P. carinii. Deter...
主要な著者: | Champness, J, Achari, A, Ballantine, S, Bryant, P, Delves, C, Stammers, D |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
1994
|
類似資料
-
The structure of Pneumocystis carinii dihydrofolate reductase to 1.9 A resolution.
著者:: Champness, J, 等
出版事項: (1994) -
Preliminary crystallographic data for Pneumocystis carinii dihydrofolate reductase.
著者:: Stammers, D, 等
出版事項: (1993) -
Refolding of recombinant Pneumocystis carinii dihydrofolate reductase and characterization of the enzyme.
著者:: Delves, C, 等
出版事項: (1993) -
The binding of trimethoprim to bacterial dihydrofolate reductase.
著者:: Baker, D, 等
出版事項: (1981) -
Synthesis of 2,4-Diaminopteridines with Bulky Lipophilic Groups at the 6-Position as Inhibitors of Pneumocystis carinii, Toxoplasma gondii, and Mammalian Dihydrofolate Reductase
著者:: Rosowsky Andre, 等
出版事項: (1997-09-01)